The Series C round was led by a strategic investor and backed by existing supporters to drive international expansion.
"We are delighted to continue backing the ambitious CGD team in bringing groundbreaking GaN technologies to market. As we strive towards a low-carbon future, CGD’s products can deliver higher performance while enabling up to 50% energy savings across multiple growing sectors such as automotive, renewable energy, and data centres. We look forward to seeing the impact that CGD can make in enabling greener power electronics"
The capital will fuel international expansion, product innovation, and enterprise growth.
"This investment marks another exciting milestone for Hands In. Our success with Air Europa demonstrated the power of our multi-card solution in reducing payment failures and increasing conversions. With this new funding, we’re poised to scale our split payment technology, onboard more enterprise clients, and redefine split payments globally."
Point72 Private Investments led the round to support global expansion and research initiatives.
"We know this market well and strongly believe in the power of next-generation AI to revolutionise contracting processes across the enterprise. We are excited to back Luminance as it continues building a specialist and trusted technology that has already been adopted by many of the world’s largest organizations. Their team, strategy and vision positions them well to win this market."
ETF Partners led the Series B round to support the company as it scales its footprint across Europe and the US.
"Our AI agents take away the annoying bits of the work, empowering humans to focus on actually delivering projects on time and on budget, and in doing so, benefiting entire communities. This funding allows us to expand our reach, transforming construction at a time when smarter solutions are critical."
Redalpine led the pre-seed round to help the startup bring its wearable hormone sensors to market and expand its team.
"We did it for blood pressure and will do it again for hormones. Continuous hormone measurement is one of the holy grails of diagnostics, and as fundamental science transitions to engineering, we couldn’t be more excited to back Level Zero Health in their mission to transform hormone tracking with their novel biosensor – paving the way for a new era of personalized health management."
.png)
